Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490251 · ClinicalTrials.gov registry record
Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 95
- Enrollment target
NCT05490251: Completed study, sponsored by Virginia Commonwealth University.
NCT05490251 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05490251 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.
Primary Outcome
Examine racial differences in acute stress responses using a validated psychological stress challenge called the Trier Social Stress Test (TSST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2025-08-31 |
What the finished NCT05490251 record still lists
NCT05490251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05490251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05490251 about?
NCT05490251 is a clinical study titled "Translational Research Center in Lung Cancer Disparities (TRACER) Project 2". The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.
What is the current status of trial NCT05490251?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2024-01-31. Estimated completion is 2025-08-31.
Who is sponsoring clinical trial NCT05490251?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI